Premium
Ganciclovir treatment in Ménétrier's disease
Author(s) -
Hoffer V,
Finkelstein Y,
Balter J,
Feinmesser M,
Garty BZ
Publication year - 2003
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.2003.tb00637.x
Subject(s) - medicine , hypoalbuminemia , ganciclovir , oliguria , gastroenterology , vomiting , albumin , surgery , human cytomegalovirus , immunology , virus , renal function
A 2‐y‐old girl with severe edema, oliguria and hypoalbuminemia caused by protein‐losing gastritis was diagnosed with cytomegalovirus‐associated Ménétrier's disease. After almost two weeks, during which the patient required repeated albumin transfusions, she was treated with intravenous ganciclovir. Within five days her condition had improved, and no additional albumin replacement was needed. Complete recovery was observed after several weeks. Conclusion : In patients with severe Ménétrier's disease, a course of ganciclovir treatment may be of benefit and should be considered.